Peichel, who has worked at Medtronic for more than 25 years, succeeds Ken Washington, who retired earlier this month.

By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 ...

The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...

The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.

Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device ...

Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...

The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer ...

Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston ...

By targeting ambulatory surgery centers, the company is gearing up to compete with Intuitive Surgical for an emerging ...

GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal ...